India's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...

The landscape of India's anti-obesity drug market has reached a point of refinement. While there are affordable generic options, their upta...

India continues its strong support for Afghanistan, reaffirms MEA. The nation is focused on peace, stability, and development. This include...

The recent trade accord between India and Oman represents a significant leap toward energy independence and economic integration. Experts n...

Indian stock markets are facing tough times due to global economic factors. Deepak Shenoy of Capitalmind MF advises investors to look beyon...

Indian equities face a mixed outlook due to potential monsoon deficit and uneven corporate earnings. While rural-linked sectors may see pre...

ValueQuest's Sameer Shah champions a private equity approach to public markets. He focuses on deep research and conviction in identifying t...

Market expert Sunil Subramaniam advised caution amid geopolitical uncertainty and rising input costs, while favouring consumer durables, ca...

India and Italy are shaping an Indo-Mediterranean partnership focused on trade, AI, defence, clean energy and connectivity, with Narendra M...

Journalist Saurabh Dwivedi's acting debut in Netflix's 'Kartavya' sparked online mockery, igniting a debate on India's culture of online ri...

Indian equity markets fell for a fourth straight session as rising crude oil prices, geopolitical tensions, FII selling, and a record-low r...

The United States is accelerating research into psychedelic drugs for mental illness. This shift prompts India to re-evaluate its own drug ...

As innovation evolves beyond industry boundaries, the AI Special Product / Innovation category at the ET Most Innovative AI Product Awards ...

The Life Sciences & Pharma category at the ET Most Innovative AI Product Awards 2026. Recognises organisations leveraging AI to accelerate ...

As global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.

Indian companies are increasingly making bold acquisitions abroad. Sun Pharma's deal signals a new era of deliberate empire-building. This ...

Sun Pharma, led by Dilip Shanghvi, has agreed to acquire US-based Organon in an all-cash deal worth $11.75 billion, marking the largest acq...